Showing results (71-80 of 12,899) with videos related to
Sort By:
Pageof 1,290
Circulation|February 6, 2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trialMarc S Sabatine, David A Morrow, Robert P Giugliano, et al.Circulation|November 9, 2000
Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudyH V Barron, C P Cannon, S A Murphy, et al.The American Journal of Cardiology|March 7, 2001
Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 InvestigatorsC P Cannon, C H McCabe, R G Wilcox, et al.Journal of the American College of Cardiology|August 1, 2006
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapyChristopher P Cannon, Benjamin A Steinberg, Sabina A Murphy, et al.Journal of the American College of Cardiology|January 20, 2010
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trialSabina A Murphy, Christopher P Cannon, Stephen D Wiviott, et al.European Heart Journal|July 3, 2004
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studiesDavid A Morrow, Elliott M Antman, Sabina A Murphy, et al.Circulation|November 18, 2005
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 TrialMarc S Sabatine, David A Morrow, Gilles Montalescot, et al.American Heart Journal|March 3, 2009
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarctionRoberto R Giraldez, Marc S Sabatine, David A Morrow, et al.Lancet (London, England)|March 3, 2009
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trialGilles Montalescot, Stephen D Wiviott, Eugene Braunwald, et al.European Heart Journal|September 29, 2004
Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarctionAmir Kashani, Robert P Giugliano, Elliott M Antman, et al.Pageof 1,290